VIRIDIAN THERAPEUTICS INC

Ticker: VRDN CUSIP: 92790C104 Class: Common Stock

BALYASNY ASSET MANAGEMENT L.P.'s Holding History (CIK: 0001218710)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 503,868 Value ($000) $15,680 Avg Close $27.43 Range $20.69 - $34.04

Q3 2025

Shares 202,821 Value ($000) $4,377 Avg Close $18.04 Range $13.84 - $21.72

Q4 2024

Shares 130,721 Value ($000) $2,506 Avg Close $21.74 Range $17.06 - $27.20

Q3 2024

Shares 339,089 Value ($000) $7,714 Avg Close $16.35 Range $11.85 - $23.80

Q4 2023

Shares 41,214 Value ($000) $898 Avg Close $15.79 Range $10.93 - $23.53

Q3 2023

Shares 13,969 Value ($000) $214 Avg Close $19.08 Range $14.64 - $25.05

Q4 2022

Shares 304,552 Value ($000) $8,896 Avg Close $23.04 Range $18.00 - $29.99

Q3 2022

Shares 169,529 Value ($000) $3,477 Avg Close $17.98 Range $10.47 - $26.22

Q1 2022

Shares 16,303 Value ($000) $301 Avg Close $19.21 Range $15.93 - $21.50

Q2 2021

Shares 119,478 Value ($000) $2,185 Avg Close $17.12 Range $14.24 - $18.99

Q1 2021

Shares 119,576 Value ($000) $1,998 Avg Close $18.72 Range $14.65 - $25.67

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	503,868	$15,680	$27.43	$20.69 - $34.04
Q3 2025	202,821	$4,377	$18.04	$13.84 - $21.72
Q4 2024	130,721	$2,506	$21.74	$17.06 - $27.20
Q3 2024	339,089	$7,714	$16.35	$11.85 - $23.80
Q4 2023	41,214	$898	$15.79	$10.93 - $23.53
Q3 2023	13,969	$214	$19.08	$14.64 - $25.05
Q4 2022	304,552	$8,896	$23.04	$18.00 - $29.99
Q3 2022	169,529	$3,477	$17.98	$10.47 - $26.22
Q1 2022	16,303	$301	$19.21	$15.93 - $21.50
Q2 2021	119,478	$2,185	$17.12	$14.24 - $18.99
Q1 2021	119,576	$1,998	$18.72	$14.65 - $25.67